peculation in recent months has centered on how GLP-1 agonists such as Ozempic, Trulicity and Mounjaro may impact food and beverage demand. From a product development perspective, the medications may turn consumer attention to satiety and how ingredients like fiber, protein and the sweetener allulose may keep consumers, Read more

Join your peers today!

Get the latest articles, news and trends in the Food & Beverage industry delivered directly to your inbox. Don't miss out! Enter your email address below to receive the weekly in-sight newsletter.


Happy Holidays from Symrise! See you in 2024!

Thank you for reading and sharing in-sight in 2023! We're taking a holiday…

Insights From the StarChefs Panel Discussion in Austin, Texas

As host of the food-centric podcast Flavors Unknown, Emmanuel Laroche knows his…